Publication: Going up the hill: chromatin-based barriers to epigenetic reprogramming
dc.contributor.coauthor | Terzioglu, Gizem | |
dc.contributor.coauthor | Bayirbasi, Busra | |
dc.contributor.department | School of Medicine | |
dc.contributor.department | Graduate School of Sciences and Engineering | |
dc.contributor.kuauthor | Arabacı, Hilal Dilşad | |
dc.contributor.kuauthor | Önder, Tamer Tevfik | |
dc.contributor.schoolcollegeinstitute | GRADUATE SCHOOL OF SCIENCES AND ENGINEERING | |
dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
dc.date.accessioned | 2024-11-09T23:03:58Z | |
dc.date.issued | 2021 | |
dc.description.abstract | The establishment and maintenance of cellular identity are crucial during development and tissue homeostasis. Epigenetic mechanisms based largely on DNA methylation and histone modifications serve to reinforce and safeguard differentiated cell states. Somatic cell nuclear transfer (SCNT) or transcription factors such as Oct4, Sox2, Klf4, c-MYC (OSKM) can erase somatic cell identity and reprogram the cells to a pluripotent state. In doing so, reprogramming must reset the chromatin landscape, silence somatic-specific gene expression programs, and, in their place, activate the pluripotency network. In this viewpoint, we consider the major chromatin-based barriers for reprogramming of somatic cells to pluripotency. Among these, repressive chromatin modifications such as DNA methylation, H3K9 methylation, variant histone deposition, and histone deacetylation generally block the activation of pluripotency genes. In contrast, active transcription-associated chromatin marks such as DOT1L-catalyzed H3K79 methylation, FACT-mediated histone turnover, active enhancer SUMOylation, and EP300/CBP bromodomain-mediated interactions act to maintain somatic-specific gene expression programs. We highlight how genetic or chemical inhibition of both types of barriers can enhance the kinetics and/or efficiency of reprogramming. Understanding the mechanisms by which these barriers function provides insight into how chromatin marks help maintain cell identity. | |
dc.description.indexedby | WOS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 16 | |
dc.description.openaccess | NO | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | TUBITAK-BIDEB scholarship - TUBITAK [213S182] | |
dc.description.sponsorship | Newton Advanced Fellowship We would like to thank members of TTO laboratory for critical reading of the manuscript. DHA is funded by a TUBITAK-BIDEB scholarship. Work in TTO laboratory was funded by TUBITAK grant 213S182 and by a Newton Advanced Fellowship. | |
dc.description.volume | 288 | |
dc.identifier.doi | 10.1111/febs.15628 | |
dc.identifier.eissn | 1742-4658 | |
dc.identifier.issn | 1742-464X | |
dc.identifier.scopus | 2-s2.0-85097252085 | |
dc.identifier.uri | https://doi.org/10.1111/febs.15628 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/8559 | |
dc.identifier.wos | 595853900001 | |
dc.keywords | Chromatin | |
dc.keywords | Epigenetics | |
dc.keywords | Pluripotent stem cells | |
dc.keywords | Reprogramming pluripotent stem-cells | |
dc.keywords | Novo DNA methylation | |
dc.keywords | Nuclear transfer | |
dc.keywords | Somatic-Cells | |
dc.keywords | Transcription factors | |
dc.keywords | Super-enhancers | |
dc.keywords | Expression | |
dc.keywords | Identity | |
dc.keywords | Effıciency | |
dc.keywords | Induction | |
dc.language.iso | eng | |
dc.publisher | Wiley | |
dc.relation.ispartof | Febs Journal | |
dc.subject | Biochemistry | |
dc.subject | Molecular biology | |
dc.title | Going up the hill: chromatin-based barriers to epigenetic reprogramming | |
dc.type | Journal Article | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Arabacı, Hilal Dilşad | |
local.contributor.kuauthor | Önder, Tamer Tevfik | |
local.publication.orgunit1 | GRADUATE SCHOOL OF SCIENCES AND ENGINEERING | |
local.publication.orgunit1 | SCHOOL OF MEDICINE | |
local.publication.orgunit2 | School of Medicine | |
local.publication.orgunit2 | Graduate School of Sciences and Engineering | |
relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isOrgUnitOfPublication | 3fc31c89-e803-4eb1-af6b-6258bc42c3d8 | |
relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isParentOrgUnitOfPublication | 434c9663-2b11-4e66-9399-c863e2ebae43 | |
relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | 434c9663-2b11-4e66-9399-c863e2ebae43 |